SherpaBonds
US78081BAN38 · Corp · USDInvestment Grade · Baa2

Royalty Pharma Plc 2.15% 2031/09

Royalty Pharma PlcUnited StatesGLOBALSenior Unsecured
SHARE
▶ Start radio
MID PRICE
88.10
par = 100
YIELD TO MAT.
4.79%
semi-annual
COUPON
2.150%
semi-annual · fixed
MATURITY
2031-09-02
bullet · 5.32y
OUTSTANDING
—
not disclosed
AS OF
2026-05-07

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Sign inSign up free

About this bond

AI BRIEF · GROUNDED IN STRUCTURED DATA
About the issuer

Royalty Pharma is a private equity investor firm founded in 1996. It purchases the rights to royalties on future drug sales. It claims to own partial rights to 7 of the top 30 selling drugs in the United States.

Source: Wikipedia →

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
4.89 y
1bp ↑ ≈ -0.049% P&L
Convexity
27.27
higher = more curvature
Years to maturity
5.32 y
YTM source
Ingested
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
Vanguard Intermediate-Term Corporate Bond
Vanguard
US Corporate Intermediate$20.4M—0.03%2026-03-31
Vanguard Intermediate-Term Bond
Vanguard
US Aggregate Intermediate$5.2M—0.01%2026-03-31
iShares 5-10 Year Investment Grade Corporate Bond
iShares
US IG Corporate$4.8M▼ $8K0.03%2026-05-07
iShares iBonds Dec 2031 Term Corporate
iShares
iBonds 2031 Corporate$3.4M▼ $10K0.14%2026-05-07
iShares Core U.S. Aggregate Bond
iShares
US Aggregate$2.7M▼ $8K0.00%2026-05-07
Vanguard Total Bond Market
Vanguard
US Aggregate$2.6M—0.00%2026-03-31
Invesco BulletShares 2031 Corporate Bond
Invesco
BulletShares 2031 Corporate$2.5M▲ $5K0.15%2026-05-05
SPDR Portfolio Intermediate Term Corporate Bond
SPDR
US IG Corporate Intermediate$1.3M▲ $1K0.01%2026-05-05
iShares Broad USD Investment Grade Corporate Bond
iShares
US Broad IG Corporate$1.3M▼ $2K0.01%2026-05-07
iShares Core Universal USD Bond
iShares
US Aggregate$524K▼ $2K0.00%2026-05-07
iShares Intermediate Government/Credit Bond
iShares
US Govt/Credit$122K▲ $4K0.00%2026-05-07
iShares BBB Rated Corporate Bond
iShares
US IG Corporate$44K▲ $9K0.08%2026-05-07
iShares ESG Advanced Universal USD Bond
iShares
US Aggregate$22K▲ $4K0.00%2026-05-07
iShares Core 5-10 Year USD Bond
iShares
US Aggregate$22K▼ $660.01%2026-05-07
iShares Interest Rate Hedged U.S. Aggregate Bond
iShares
US Aggregate$96—0.00%2026-05-07
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-05-07

Institutional footprint · signal-level holdings

60/ 100Broad ownership
Interpretation. Moderate institutional footprint, with net accumulation
HOLDERS
15
▲ 5 signals in 7d
AGGREGATE EXPOSURE
$44.8M
USD across all
TOP CONCENTRATION
45.6%
largest holder
FLOW
▲ $1.8M
▲ 5 signals in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
88,101 USD
PRICE
88.10

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
RPRX 2.15 09/02/31
FIGI
BBG011V71QR8
CUSIP
78081BAN3
ISIN
US78081BAN38
Type
Corp
Issued
2021-07-26
Face value
100 USD
Ticker
RPRX 2.15 09/02/31
Sec. type
GLOBAL
Seniority
Senior Unsecured

Issuer curve

RPRX · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.

Bonds like this

HEURISTIC

Same currency & sector, maturity within 7 years. Ranked by overlapping institutional owners, issuer match, and rating distance.

Royalty Pharma Plc 4.45% 03/2031
Royalty Pharma Plc
2031-03
4.73%
−6 bps yield−5mo duration6 signals in commonSame issuer
Royalty Pharma Plc 2.2% 09/2030
Royalty Pharma Plc
2030-09
4.68%
−11 bps yield−1y duration6 signals in commonSame issuer
Royalty Pharma Plc 5.15% 09/2029
Royalty Pharma Plc
2029-09
4.60%
−19 bps yield−2y duration6 signals in commonSame issuer
Royalty Pharma Plc 5.4% 09/2034
Royalty Pharma Plc
2034-09
5.20%
+41 bps yield+3y duration7 signals in commonSame issuer
Royalty Pharma Plc 1.75% 09/2027
Royalty Pharma Plc
2027-09
4.44%
−35 bps yield−4y duration7 signals in commonSame issuer
Royalty Pharma Plc 5.2% 09/2035
Royalty Pharma Plc
2035-09
5.28%
+49 bps yield+4y duration8 signals in commonSame issuer